Orimelan (Melatonin)

Melatonin works by binding to MT1 and MT2 receptors in the brain’s suprachiasmatic nucleus. This interaction signals darkness, helping to synchronize the body’s internal clock and promote the onset of sleep. By raising circulating melatonin levels, the supplement reinforces the natural night‑time signal.

The appropriate dose of Orimelan is determined by a qualified healthcare professional based on the individual’s age, condition, and response to therapy. Patients should follow the prescriber’s instructions and not exceed the recommended amount without medical guidance.

Safety data for melatonin use during pregnancy or lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their healthcare provider before using Orimelan to weigh potential benefits against any unknown risks.

To order Orimelan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Orimelan provides melatonin, a naturally occurring hormone, whereas many other sleep‑aid products contain synthetic hypnotics such as diphenhydramine or zolpidem. Melatonin works by aligning circadian rhythms rather than directly depressing the central nervous system, often resulting in a milder side‑effect profile.

Orimelan should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct light, and ensure the container is tightly closed to maintain product stability.

Orimelan is taken orally, usually with a glass of water. It is typically taken about 30 minutes before the desired bedtime, but patients should follow the specific timing instructions provided by their prescriber.

Serious but rare risks include severe allergic reactions such as rash, swelling, or difficulty breathing, and significant hypotension. If any of these occur, medical attention should be sought immediately. Patients should also be aware of potential mood changes.

Individuals with known hypersensitivity to melatonin, those taking certain CNS depressants without medical supervision, and patients with uncontrolled depression or severe hepatic impairment should avoid using Orimelan unless directed by a healthcare professional.